1-1 of 1
Anja Porwit MacDonald
Close
Sort by
Journal Articles

A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas

Clinical Trials & Observations
Gunilla Enblad, Hans Hagberg, Martin Erlanson, Jeanette Lundin, Anja Porwit MacDonald, Roland Repp, Johannes Schetelig, Gernot Seipelt, Anders Österborg
Journal: Blood
Blood (2004) 103 (8): 2920–2924.
https://doi.org/10.1182/blood-2003-10-3389
Published: 2004